Novel method for synthesizing daclatasvir intermediate
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI FOREFRONT PHARMA CO LTD
- Publication Date
- 2015-12-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of preparation of pharmaceutical intermediates, specifically, the invention provides a method for preparing a daclatasvir intermediate. Background technique
[0002] Daclatasvir (Daclatasvir) is a hepatitis C treatment drug developed by BMSquibb, which has been marketed in the United States, Europe and Japan respectively. The clinical cure rate of hepatitis C in combination with Sofosbuvir (Sofosbuvir) can be greater than 90%. , has been included in the list of the most important essential therapeutic drugs by WHO, and has good therapeutic effects and market prospects.
[0003] In the method for preparing Daclatasvir (Daclatasvir) known in the art at present, the compound of formula I is the most important and most economical intermediate, so in order to industrialize the production of Daclatasvir, this field needs a kind of compound that can efficiently synthesize A method for a compound of formula I.
[0004] ...